Magellan Group client, Western New York BloodCare, provided a grant to the University of Buffalo School of Medicine and Biomedical Sciences to establish a fellowship in non-malignant hematology. WNY BloodCare is partnering with the UB School of Medicine and Roswell Park to address shortages in specialist in complex bleeding and thrombotic disorders.
The $675,000 grant establishes the Rosemary “Penny” Holmberg Hemostasis and Thrombosis Clinical Fellowship in non-malignant hematology at UB. It provides one to two years of training in advanced medical management of patients with complex bleeding and thrombotic disorders.
An earlier grant for $890,000 established the Robert Long Career Development Award. It invests in a junior physician-scientist who is dedicated to conducting advanced research, facilitating training for medical professionals, and providing expert care to local patients and families with these disorders.
WNY BloodCare, formerly the Hemophilia Center of WNY, is celebrating 50 Years of providing integrated care, specialty laboratory and pharmaceutical services to those with hemophilia and other bleeding and clotting disorders. WNY BloodCare changed their name to reflect the populations their serve as well as position them to expand their services to others with blood disorders. The organization moves into the Buffalo Niagara Medical Campus in early June of 2019 creating greater visibility to the medical community. The Magellan Group rebranded the organization and is responsible for the roll-out across all media, including exterior and interior signage in their new space on Main Street.
See the full article at UBMD.